Back to acquisitions

Company profile

myNEO Therapeutics

myNEO Therapeutics applies immunogenomics to discover tumor antigens and supports personalized cancer vaccines and T-cell therapy programs.

Location
Ghent, Oost-Vlaanderen, Belgium
Website
myneotx.com

Funding

No round listed

This company does not appear in the current investment-round dataset.

Acquisition

Acquired by Arcturus Therapeutics

Deal value
Undisclosed
Announced
Sep 23, 2026